Two Sigma Advisers’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,747
| Closed | -$7K | – | 2591 |
|
|
2022
Q3 | $7K | Sell |
1,747
-1,333
| -43% | -$5.34K | ﹤0.01% | 2494 |
|
|
2022
Q2 | $41K | Sell |
3,080
-520
| -14% | -$6.92K | ﹤0.01% | 2499 |
|
|
2022
Q1 | $18K | Sell |
3,600
-20,680
| -85% | -$103K | ﹤0.01% | 2670 |
|
|
2021
Q4 | $166K | Buy |
24,280
+10,013
| +70% | +$68.5K | ﹤0.01% | 2334 |
|
|
2021
Q3 | $440K | Sell |
14,267
-6,120
| -30% | -$189K | ﹤0.01% | 1978 |
|
|
2021
Q2 | $662K | Sell |
20,387
-12,933
| -39% | -$420K | ﹤0.01% | 1822 |
|
|
2021
Q1 | $1.26M | Sell |
33,320
-11,120
| -25% | -$420K | ﹤0.01% | 1522 |
|
|
2020
Q4 | $2.1M | Buy |
44,440
+5,440
| +14% | +$257K | 0.01% | 1232 |
|
|
2020
Q3 | $1.26M | Buy |
39,000
+600
| +2% | +$19.4K | ﹤0.01% | 1395 |
|
|
2020
Q2 | $1.69M | Buy |
38,400
+12,653
| +49% | +$557K | 0.01% | 1289 |
|
|
2020
Q1 | $844K | Buy |
25,747
+7,254
| +39% | +$238K | ﹤0.01% | 1577 |
|
|
2019
Q4 | $945K | Buy |
18,493
+7,160
| +63% | +$366K | ﹤0.01% | 1604 |
|
|
2019
Q3 | $417K | Sell |
11,333
-2,854
| -20% | -$105K | ﹤0.01% | 1784 |
|
|
2019
Q2 | $784K | Sell |
14,187
-466
| -3% | -$25.8K | ﹤0.01% | 1626 |
|
|
2019
Q1 | $891K | Sell |
14,653
-387
| -3% | -$23.5K | ﹤0.01% | 1578 |
|
|
2018
Q4 | $890K | Sell |
15,040
-973
| -6% | -$57.6K | ﹤0.01% | 1534 |
|
|
2018
Q3 | $1.3M | Buy |
16,013
+2,026
| +14% | +$164K | ﹤0.01% | 1407 |
|
|
2018
Q2 | $1.22M | Buy |
+13,987
| New | +$1.22M | ﹤0.01% | 1525 |
|
|
2015
Q1 | – | Sell |
-215
| Closed | -$446K | – | 1990 |
|
|
2014
Q4 | $446K | Buy |
215
+39
| +22% | +$80.9K | ﹤0.01% | 1487 |
|
|
2014
Q3 | $350K | Buy |
176
+12
| +7% | +$23.9K | ﹤0.01% | 1353 |
|
|
2014
Q2 | $581K | Buy |
164
+10
| +6% | +$35.4K | ﹤0.01% | 1268 |
|
|
2014
Q1 | $576K | Buy |
154
+2
| +1% | +$7.48K | 0.01% | 1145 |
|
|
2013
Q4 | $497K | Sell |
152
-20
| -12% | -$65.4K | ﹤0.01% | 1236 |
|
|
2013
Q3 | $722K | Buy |
172
+16
| +10% | +$67.2K | 0.01% | 864 |
|
|
2013
Q2 | $524K | Buy |
+156
| New | +$524K | 0.01% | 959 |
|